Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Future Oncology (London, England)|March 27, 2007
Deubiquitinating enzymes as novel anticancer targetsBenjamin Nicholson, Jeffrey G Marblestone, Tauseef R Butt, et al.Biochemical Society Transactions|January 16, 2010
Strategies for the identification of ubiquitin ligase inhibitorsSeth J Goldenberg, Jeffrey G Marblestone, Michael R Mattern, et al.Biochemical Society Transactions|September 17, 2008
Strategies for the identification of novel inhibitors of deubiquitinating enzymesSeth J Goldenberg, Jeffrey L McDermott, Tauseef R Butt, et al.Cell Biochemistry and Biophysics|May 23, 2013
Comprehensive ubiquitin E2 profiling of ten ubiquitin E3 ligasesJeffrey G Marblestone, Samir Butt, Devin M McKelvey, et al.Cell Biochemistry and Biophysics|March 31, 2011
Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophyMichael J Eddins, Jeffrey G Marblestone, K G Suresh Kumar, et al.Journal of Biomolecular Screening|September 25, 2010
Novel approach for characterizing ubiquitin E3 ligase functionJeffrey G Marblestone, K G Suresh Kumar, Michael J Eddins, et al.Protein Science : a Publication of the Protein Society|December 3, 2005
Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMOJeffrey G Marblestone, Suzanne C Edavettal, Yiting Lim, et al.Biochimica Et Biophysica Acta|June 23, 2012
Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteinsJeffrey G Marblestone, James P Larocque, Michael R Mattern, et al.Protein Expression and Purification|August 9, 2005
SUMO fusion technology for difficult-to-express proteinsTauseef R Butt, Suzanne C Edavettal, John P Hall, et al.Biochimica Et Biophysica Acta|May 22, 2012
Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitorsMichael R Mattern, Jian Wu, Benjamin NicholsonPageof 8